Artificial Heart Market Size - By Product Type, By Services, By Power Source, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
Global Artificial Heart Market Overview
According to SPER Market Research, the Global Artificial Heart Market is estimated to reach USD 0.81 billion by 2032 with a CAGR of 14.06%. A prosthetic device placed into the body to take the place of the biological mammalian heart is referred to as an artificial heart. Humans' natural valves and ventricles are removed in order to use the synthetic replacement as a form of mechanical circulatory support system. The equipment is often pneumatically powered.
Impact of COVID-19 on the Global Artificial Heart Market
The introduction of COVID-19 has caused a delay in elective treatments, which has hurt the market for cardiovascular devices like artificial hearts. The market for mechanical hearts was severely impacted since only life-threatening procedures were permitted, and the majority of cardiac treatments had to be postponed or cancelled because resources had to be diverted to help patients afflicted by COVID-19.
Scope of the report:
Market size available for the years 2019-2032
Base year considered 2021
Forecast Period 2022-2032
Segments Covered By Product Type, By Services, By Power Source, By End User
Regions Covered Asia Pacific, Europe, Latin America, Middle East and Africa, North America
Companies Covered Abbott, AbioMed, BiVACOR Inc., Boston Scientific Corporation, CARMAT, Cirtec Medical Systems, Cleveland Heart, CryoLife, Inc., Edwards Lifesciences Corporation,
Global Artificial Heart Market Segmentation:
By Product Type: Based on the Product Type, Global Artificial Heart Market is segmented as; Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices, Others.
By Services: Based on the Services, Global Artificial Heart Market is segmented as; Batch-Release Testing Services, Bioanalytical Testing Services, Environmental Monitoring Services, Method Development, Microbial Testing Services, Physical Characterization Services, Raw Material Testing Services, Stability Testing, Validation Services, Others.
By Region:The region with the greatest expected CAGR throughout the projection period is Asia Pacific. This market's expansion may be linked to elements including rising disposable income, more public awareness of heart disease, and an increase in the number of elderly people living in this area.
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER’s internal database
- 2.1.4 Premium insight from KOL’s
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Artificial Heart Market
- 5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER’S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4.Heat map analysis
- 6. Competitive Landscape
- 6.1. Global Artificial Heart Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Artificial Heart Market
- 7. Global Artificial Heart Market, By Product Type, 2019-2032 (USD Million)
- 7.1. Heart-Lung Machine
- 7.2. Mechanical Heart
- 7.3. Total Artificial Hearts
- 7.4. Ventricular Assist Devices
- 7.5. Others
- 8. Global Artificial Heart Market, By Services, 2019-2032 (USD Million)
- 8.1. Batch-Release Testing Services
- 8.2. Bioanalytical Testing Services
- 8.3. Environmental Monitoring Services
- 8.4. Method Development
- 8.5. Microbial Testing Services
- 8.6. Physical Characterization Services
- 8.7. Raw Material Testing Services
- 8.8. Stability Testing
- 8.9. Validation Services
- 8.10. Others
- 9. Global Artificial Heart Market, By Power Source, 2019-2032 (USD Million)
- 9.1. Internal Battery
- 9.2. External Battery
- 10. Global Artificial Heart Market, By End User, 2019-2032 (USD Million)
- 10.1. Contract Research Organizations
- 10.2. Hospitals and Clinics
- 10.3. Medical Device Companies
- 10.4. Pharmaceutical and Biopharmaceutical Companies
- 10.5. Specialty Centers
- 10.6. Others
- 11. Global Artificial Heart Market, By Region, 2019-2032 (USD Million)
- 11.1. Global Artificial Heart Size and Market Share by Region (2019-2025)
- 11.2. Global Artificial Heart Size and Market Share by Region (2026-2032)
- 11.3. Asia-Pacific
- 11.3.1. Australia
- 11.3.2. China
- 11.3.3. India
- 11.3.4. Japan
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
- 11.4. Europe
- 11.4.1. France
- 11.4.2. Germany
- 11.4.3. Italy
- 11.4.4. Spain
- 11.4.5. United Kingdom
- 11.4.6. Rest of Europe
- 11.5. Middle East & Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Rest of Middle East & Africa
- 11.6. North America
- 11.6.1. Canada
- 11.6.2. Mexico
- 11.6.3. United States
- 11.7. Latin America
- 11.7.1. Argentina
- 11.7.2. Brazil
- 11.7.3. Rest of Latin America
- 12. Company Profiles
- 12.1. Abbott
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. AbioMed
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. BIVACOR Inc.
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Boston Scientific Corporation
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. CARMAT
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Cirtec Medical Systems
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Cleveland Heart
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. CryoLife, Inc.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Edwards Lifesciences Corporation
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Jarvik Heart, Inc
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Medical Technology Est. and Medical Circle
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
- 12.12. MyLVAD
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
- 12.13. SynCardia Systems, LLC
- 12.13.1. Company details
- 12.13.2. Financial outlook
- 12.13.3. Product summary
- 12.13.4. Recent developments
- 12.14. Thoratec Corporation
- 12.14.1. Company details
- 12.14.2. Financial outlook
- 12.14.3. Product summary
- 12.14.4. Recent developments
- 13. List of Abbreviations
- 14. Reference Links
- 15. Conclusion
- 16. Research Scope
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook